Captrust Financial Advisors Ginkgo Bioworks Holdings, Inc. Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 18,190 shares of DNA stock, worth $102,773. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,190
Previous 15,193
19.73%
Holding current value
$102,773
Previous $17,000
64.71%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$808 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$785 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$760 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$395 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$237 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $7.28B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...